- Home
- VERU vs JSPR Comparison
VERU vs JSPR Comparison
Compare VERU & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERU
- JSPR
- Stock Information
- Founded
- VERU 1971
- JSPR 2018
- Country
- VERU United States
- JSPR United States
- Employees
- VERU N/A
- JSPR N/A
- Industry
- VERU Biotechnology: Pharmaceutical Preparations
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VERU Health Care
- JSPR Health Care
- Exchange
- VERU Nasdaq
- JSPR Nasdaq
- Market Cap
- VERU 76.9M
- JSPR 85.8M
- IPO Year
- VERU 1990
- JSPR N/A
- Fundamental
- Price
- VERU $0.50
- JSPR $4.77
- Analyst Decision
- VERU Strong Buy
- JSPR Strong Buy
- Analyst Count
- VERU 2
- JSPR 11
- Target Price
- VERU $4.00
- JSPR $62.22
- AVG Volume (30 Days)
- VERU 856.5K
- JSPR 152.4K
- Earning Date
- VERU 05-08-2025
- JSPR 05-12-2025
- Dividend Yield
- VERU N/A
- JSPR N/A
- EPS Growth
- VERU N/A
- JSPR N/A
- EPS
- VERU N/A
- JSPR N/A
- Revenue
- VERU $16,886,419.00
- JSPR N/A
- Revenue This Year
- VERU N/A
- JSPR N/A
- Revenue Next Year
- VERU N/A
- JSPR N/A
- P/E Ratio
- VERU N/A
- JSPR N/A
- Revenue Growth
- VERU 134.43
- JSPR N/A
- 52 Week Low
- VERU $0.45
- JSPR $3.13
- 52 Week High
- VERU $1.42
- JSPR $26.84
- Technical
- Relative Strength Index (RSI)
- VERU 44.61
- JSPR 49.05
- Support Level
- VERU $0.48
- JSPR $4.57
- Resistance Level
- VERU $0.56
- JSPR $5.20
- Average True Range (ATR)
- VERU 0.02
- JSPR 0.37
- MACD
- VERU -0.00
- JSPR -0.00
- Stochastic Oscillator
- VERU 30.83
- JSPR 53.76
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.